As of 2026-09-10, the Relative Valuation of Kiniksa Pharmaceuticals Ltd (KNSA) is 78.55 USD. This relative valuation is based on P/E multiples. With the latest stock price at 78.52 USD, the upside of Kiniksa Pharmaceuticals Ltd based on Relative Valuation is 0.0%.
The range of the Relative Valuation is 78.53 - 78.57 USD.
| Range | Selected | |
| Trailing P/E multiples | 76.0x - 76.0x | 76.0x |
| Forward P/E multiples | 67.3x - 67.3x | 67.3x |
| Fair Price | 78.53 - 78.57 | 78.55 |
| Upside | 0.0% - 0.1% | 0.0% |
| Date | P/E |
| 2026-09-09 | 75.95 |
| 2026-09-08 | 74.57 |
| 2026-09-04 | 75.36 |
| 2026-09-03 | 77.84 |
| 2026-09-02 | 77.28 |
| 2026-09-01 | 76.69 |
| 2026-08-31 | 76.06 |
| 2026-08-28 | 75.53 |
| 2026-08-27 | 77.19 |
| 2026-08-26 | 76.11 |
| 2026-08-25 | 77.58 |
| 2026-08-24 | 76.78 |
| 2026-08-21 | 76.45 |
| 2026-08-20 | 75.90 |
| 2026-08-19 | 78.16 |
| 2026-08-18 | 76.89 |
| 2026-08-17 | 76.59 |
| 2026-08-14 | 74.24 |
| 2026-08-13 | 75.28 |
| 2026-08-12 | 75.59 |
| 2026-08-11 | 75.26 |
| 2026-08-10 | 74.03 |
| 2026-08-07 | 73.57 |
| 2026-08-06 | 74.01 |
| 2026-08-05 | 75.53 |
| 2026-08-04 | 73.50 |
| 2026-08-03 | 71.01 |
| 2026-07-31 | 71.91 |
| 2026-07-30 | 75.64 |
| 2026-07-29 | 78.27 |
| 2026-07-28 | 76.84 |
| 2026-07-27 | 61.46 |
| 2026-07-24 | 60.78 |
| 2026-07-23 | 60.99 |
| 2026-07-22 | 60.40 |
| 2026-07-21 | 61.47 |
| 2026-07-20 | 60.53 |
| 2026-07-17 | 61.86 |
| 2026-07-16 | 59.11 |
| 2026-07-15 | 59.67 |
| 2026-07-14 | 59.95 |
| 2026-07-13 | 58.95 |
| 2026-07-10 | 61.37 |
| 2026-07-09 | 63.24 |
| 2026-07-08 | 62.64 |
| 2026-07-07 | 65.09 |
| 2026-07-06 | 60.72 |
| 2026-07-02 | 62.42 |
| 2026-07-01 | 60.83 |
| 2026-06-30 | 61.86 |